Clinical Trial

A Clinical Study of SCTB41 Combined With Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer（Phase II Study Ongoing）

Name: A Clinical Study of SCTB41 Combined With Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer（Phase II Study Ongoing） — clinical trial record (NCT07609251)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study aims to evaluate the safety and efficacy of SCTB41 combined with docetaxel in patients with previously treated non-small cell lung cancer. The Phase II part of this study is an open-label, multicenter clinical trial.

Trial Details

NCT Number	NCT07609251
Lead Sponsor	Sinocelltech Ltd.
Conditions	NSCLC (Advanced Non-small Cell Lung Cancer)
Enrollment	90 participants
Start Date	2026-05
Primary Completion	2028-10 (estimated)
Study Completion	2029-07 (estimated)
Updated on ClinicalTrials.gov	2026-05-27